Jadwal Sholat

Memuat jadwal sholatโ€ฆ

Pendidikan editorial

Open AccessOA2022

Machine Learning Applications in Drug Repurposing

This digest summarizes a paper on using machine learning for drug repurposing, highlighting strategies, precision medicine applications, and a COVID-19 case study with traditional Chinese medicine.
Fan Yang; Qi Zhang; Xiao-Kang Ji; Yan-Chun Zhang; Wentao Li; Shao-Liang Peng; Fu-Zhong Xueยท Interdisciplinary Sciences Computational Life Sciencesยท 2022ยท DOI 10.1007/s12539-021-00487-8

The core problem

The COVID-19 pandemic has intensified efforts to repurpose existing drugs, though evidence quality varies. Drug repurposing leverages known drugs or combinations for new medical scenarios, accelerating preclinical development by saving time and cost compared to de novo discovery. The surge in publicly available large-scale data and machine learning (ML) methods enables state-of-the-art data science applications to identify drugs, diseases, therapeutics, and targets with minimal error. This article provides guidelines on ML strategies for drug repurposing, discusses precision medicine applications, and illustrates how ML can accelerate COVID-19 drug repurposing via traditional Chinese medicine (TCM) therapy.

Innovation

The authors outline strategies for employing ML in drug repurposing, focusing on data-driven approaches. They discuss how to utilize ML methods to study precision medicine and, as an instance, how ML can accelerate COVID-19 drug repurposing by developing TCM therapy. The methodology likely involves integrating diverse data sources (e.g., genomic, chemical, clinical) and applying ML algorithms to predict drug-disease associations. Specific techniques may include supervised learning, network-based methods, and deep learning, though the abstract does not detail them. The approach emphasizes leveraging massive observed data from existing drugs and diseases to identify repurposing candidates with high accuracy.
Introduction
The COVID-19 pandemic has intensified efforts to repurpose existing drugs, though evidence quality varies. Drug repurposing leverages known drugs or combinations for new medical scenarios, accelerating preclinical development by saving time and cost compared to de novo discovery. The surge in publicly available large-scale data and machine learning (ML) methods enables state-of-the-art data science applications to identify drugs, diseases, therapeutics, and targets with minimal error. This article provides guidelines on ML strategies for drug repurposing, discusses precision medicine applications, and illustrates how ML can accelerate COVID-19 drug repurposing via traditional Chinese medicine (TCM) therapy.

Why it matters

The authors discuss the advantages of ML in drug repurposing, including time and cost savings, and the ability to handle large-scale data. They highlight the role of ML in precision medicine and pandemic response, using COVID-19 and TCM as an example. The article concludes that ML methods are highly suitable for drug repurposing, offering a robust approach to identify therapeutic options quickly. Challenges may include data quality, model interpretability, and validation, but the overall outlook is promising for integrating ML into drug discovery pipelines.

Who should read this

Pembaca Research Digest dan praktisi rumpun ini.

Opening member contentโ€ฆ